GAL-021, CAS 1380341-99-0

Product Description: GAL-021 is a potent BKCa-channel blocker. GAL-021 inhibits KCa1.1 in GH3 cells. GAL-021 is a novel breathing control modulator that is based on selective modification of the almitrine pharmacophore. GAL-021 increases minute ventilation in rats and non-human primates[1][2].

Applications: COVID-19-immunoregulation

Formula: C11H22N6O

References: [1]Golder FJ, et al. Identification and Characterization of GAL-021 as a Novel Breathing Control Modulator. Anesthesiology. 2015 Nov;123(5):1093-104./[2]J F McLeod, et al. GAL-021, a new intravenous BKCa-channel blocker, is well tolerated and stimulates ventilation in healthy volunteers. Br J Anaesth. 2014 Nov;113(5):875-83.

CAS Number: 1380341-99-0

Molecular Weight: 254.33

Compound Purity: 99.89

Research Area: Inflammation/Immunology

Solubility: DMSO : ≥ 30 mg/mL

Target: Potassium Channel

• Artikelnummer: MEXHY-101422-25
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-101422-25
• Green Labware: Nein
• Verpackungseinheit: 25 mg
• Mengeneinheit: STK